The life and health industry is one of the important industries in the future, and its future prospects are broad. With the acceleration of population aging and the increase in health awareness, the demand for health services will continue to increase. At the same time, the development of emerging technologies, such as multi-omics technology, gene editing, artificial intelligence, 3D printing, etc., has shown great potential to promote the development of the life and health industry. In the future, the life and health industry will involve medical devices, health care, drug research and development, health management and other fields, and become an important pillar of China's scientific and technological innovation and industrial development.
How can universities, research institutes, medical institutions, and biomedicine in the field of life and health become future leaders in life and health? What will be the current frontier and future development of life and health? How can individuals become leaders?
On the afternoon of December 22, 2023, the main thematic forum of the 2023 China Overseas Talent Exchange Conference and the 25th Guangzhou Science and Technology Exchange Conference for Chinese Overseas Students (hereinafter referred to as the 2023 Shanghai Trade Fair), the "2023 Guangzhou Life and Health Future Leading Talent Forum" will be held in Guangzhou. Focus on the frontier and future of biomedical technology and industry, conduct in-depth exchanges, build a platform for the exchange of high-level talents, industry leaders and technological achievements at home and abroad in the field of biomedicine, and help promote the innovation and development of the life and health industry.
It is reported that 2023 is the 110th anniversary of the founding of the European and American Returned Scholars Association and the 25th anniversary of the establishment of the Overseas Trade Fair. Co-sponsored by the Ministry of Education, the European and American Returned Scholars Association (Chinese Overseas Students Association) and the people of Guangzhou**, the fair will be held on December 22-23, 2023.
The 2023 Guangzhou Life and Health Future Leading Talent Forum is organized by the people of Yuexiu District and the Guangdong Precision Medicine Application Society, and co-organized by the Bio Island Laboratory, the Guangdong-Hong Kong-Macao Greater Bay Area Precision Medicine Research Institute, the Yuexiu District Science, Technology, Industry and Information Technology Bureau, the Management Committee of Huanghuagang Science and Technology Park of Guangzhou High-tech Industrial Development Zone, the Guangdong Respiratory and Health Society, and the Guangdong Research Institute of New Biomaterials and High-end Medical Devices.
For more information, please visit the official website of the Guangdong Precision Medicine Application Society, or follow the WeChat of the "Precision Medicine Society".
Preview of the highlights
1. The Development and Future of Traditional Chinese Medicine
Liu Liang is an academician of the Chinese Academy of Engineering.
2. China: How implementation science approach can improve continuously patient safety in emergency medicine?》
Abdelouahab Bellou is a tenured professor at the University of Rennes, France, and a former associate professor of emergency medicine at Harvard Medical School in Boston, president of the European Association of Emergency Medicine (EUSEM), and president of the Global Network for Emergency Medicine.
3. "Medical Device Industry Development Status and Future Trends".
Luo Fuzhou is a researcher at the Southern Institute of Pharmaceutical Economics, National Medical Products Administration.
4. "Exploring the Way of Innovation and Entrepreneurship of China's High-end Medical Devices".
Ma Qiang, Executive Vice President of Guangdong Research Institute of New Biomaterials and High-end Medical Devices.
5. Innovation and Transformation of High-end Equipment for Life Sciences
Meng Zhao is a researcher at the Bio-Island Laboratory and the head of the Micro-Nano Technology R&D and Innovation Center of the Laboratory.
6. "The Frontier and Future of Supercomputing and Life and Health".
Lu Yutong is a professor at the School of Computer Science at Sun Yat-sen University and the director of the National Supercomputer Guangzhou Center.
Speaker's demeanor
Professor Liang Liu, MD, Academician of the Chinese Academy of Engineering, Academician of the National Academy of Inventors of the United States, Director of the National Key Laboratory of Traditional Chinese Medicine Syndromes, Director of the Academic Committee of Guangzhou University of Chinese Medicine, Dean of the Institute of Integrated Traditional Chinese and Western Medicine Innovation of Guangzhou University of Chinese Medicine, Chief Scientist of Guangdong Academy of Traditional Chinese Medicine, Consultant and Chairman of the Expert Group of the World Health Organization Traditional Medicine Project, Chairman of ISO TC249 Working Group 1 of the International Organization for Standardization (ISO) Technical Committee on Traditional Chinese Medicine, He is the president of the Chinese Medicine Immunology Branch of the Chinese Society of Immunology, and the chairman of the Chinese Medicine Immunology Professional Committee of the World Federation of Chinese Medicine Societies. He was the President of Macau University of Science and Technology, the Director of the State Key Laboratory of Quality Research in Chinese Medicine, and the Founding Dean of the School of Chinese Medicine of Hong Kong Baptist University.
Academician Liu is a well-known expert in Chinese medicine research, mainly engaged in clinical and basic research on the diagnosis and treatment of rheumatism with Chinese medicine, and the research and development of new anti-arthritis drugs. Academician Liu has created a new technology and a new molecular diagnosis method for the detection of serum biomarkers for rheumatism, which has significantly improved the diagnosis level of rheumatism in traditional Chinese and Western medicine in China. Successfully developed the first new rheumatism drug acting on prostaglandin E2 ultimate synthetase-1 (MPGES-1) - Zhengqingfeng Tingning, which is the only new drug of rheumatology monomeric compound that has been included in the dual list of national medical insurance and essential drugs, filling the gap in the field of anti-arthritis drugs at home and abroad; It has established a new research method for rheumatology, opened up a new path of traditional Chinese medicine, and promoted the development of rheumatology in China.
He has undertaken or participated in more than 50 research projects funded by the National Natural Science Commission of China and the National Science and Technology Major Basic Research Projects (973 Program and Climbing Program) of the Ministry of Science and Technology, and published more than 300 articles in SCI academic journals, including Nature and Science Supplements, Nature Communications, Annual Waters of Rheumatic Diseases and other internationally renowned academic journals. The total impact factor is more than 1500, and 43 international patents have been granted as the first inventor. He has won 19 awards and honorary titles, including 2 second prizes of the National Science and Technology Progress Award, 2 first prizes of the Natural Science Award of the Ministry of Education, and 5 first and second prizes of other ministries (provinces). He has edited or participated in the compilation and publication of 18 academic monographs and textbooks. He has successively won the first National Innovation Award, the National Young and Middle-aged Experts with Outstanding Contributions, the Cross-Century Outstanding Talent of the Ministry of Education, the Honorary Certificate of the Macao Special Administrative Region, and the 9th Shulan Medical Award.
Abdelouahab Bellou is a tenured professor at the University of Rennes, France, and a former associate professor of emergency medicine at Harvard Medical School in Boston, president of the European Association of Emergency Medicine (EUSEM), and president of the Global Network for Emergency Medicine.
Luo Fuzhou is a researcher of the Medical Device Working Group of the Southern Institute of Pharmaceutical Economics, National Medical Products Administration. His main research interests are the economics and regulatory policies of the medical device industry. Participated in the compilation of the "Status Quo of China's Medical Device Industry Development Report and the Outlook of the 14th Five-Year Plan" and "Analysis of the Safety Situation of Medical Devices". Participate in the "14th Five-Year Plan" for provincial and municipal drug safety and high-quality development, the medical device industry development plan, and the analysis of medical device inspection and testing needs. He has in-depth research on data analysis, online sales monitoring, risk management and safety situation assessment of the medical device industry.
Ma Qiang, Executive Vice President of Guangdong Research Institute of New Biomaterials and High-end Medical Devices.
He used to be the deputy director of the National Engineering Technology Research Center for Human Tissue Function Reconstruction; Chief of the Development Section of the Science and Technology Department of South China University of Technology, Vice President of the Institute of Biomedical Engineering, Secretary of the Party Committee of the School of Materials Science and Engineering, and Director of the Laboratory and Equipment Management Office.
He has been engaged in the transformation of scientific and technological achievements, project management, asset management and other aspects of colleges and universities for a long time, focusing on the transformation and incubation of new biomaterials and high-end medical device achievements, undertaking or participating in 8 scientific and technological projects including 3 national projects, publishing more than 20 articles in journals including three major index journals, and winning 1 first prize of Guangdong Science and Technology Award and 1 third prize of Guangzhou Science and Technology Award for scientific and technological progress.
Meng Zhao is a researcher at the Bio-Island Laboratory and the director of the Micro-Nano Technology R&D and Innovation Center. He holds a bachelor's degree in materials science and engineering from Tsinghua University, and is a postdoctoral fellow and visiting researcher at Delft University of Technology in the Netherlands. Founder of Dud Design in the Netherlands, founder and general manager of Guangzhou Guanghan Biotechnology.
He has been engaged in research work related to material analysis and characterization technology and in-situ detection technology for a long time, and has published 41 academic articles, been cited more than 1,300 times, and applied for more than 20 patents. At present, he is mainly engaged in the development and industrialization of new materials, new technologies and instruments and equipment for POCT biodetection based on microchips.
Lu Yutong is a professor at the School of Computer Science at Sun Yat-sen University and the director of the National Supercomputer Guangzhou Center. Sun Yat-sen University, Professor and Ph.D. supervisor of the School of Computer Science, National University of Defense Technology, Director of the National Supercomputing Guangzhou Center, Deputy Chief Designer of Tianhe-2, International Supercomputing ISC Fellow, Member of the National Key R&D Program High Performance Computing Expert Group, and Leader of the Innovation Team of the Pearl River Talent Program of Guangdong Province. He has been engaged in the research and implementation of parallel software and large-scale data processing of domestic high-performance computing systems for a long time, participated in the development of the fifth-generation Galaxy system and the two-generation Tianhe system, and has made a series of important technological innovations and breakthroughs in the field of high-performance computing core key system software and application research, and has won 1 special prize and 1 first prize of the National Science and Technology Progress Award, 4 first prizes and 6 second prizes of the Military Science and Technology Progress Award. He has published more than 100 articles in important magazines and conferences at home and abroad, and has 21 patents. She has made keynote speeches at top international supercomputing conferences SC, ISC, IPDPS for many times, and has served as the deputy editor-in-chief of IEEE TPDS, as well as the director of TPC and CCF of many important international conferences, and the director of the CWF Women's Working Committee. At present, he is committed to the research and implementation of technology, system and application of supercomputing and big data artificial intelligence integration and innovation.